Evidence map›Paper›PMID 32687186›Full record

ArticleAmerican journal of clinical pathology2020

Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.

Blake W Buchan, Jessica S Hoff, Cameron G Gmehlin, Adriana Perez, Matthew L Faron, L Silvia Munoz-Price, Nathan A Ledeboer

Open access · bronzeAbstract read
In one paragraph

Article in American journal of clinical pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Ct,Future science OA · 2023
    Article
  4. Post-COVID-19 Syndrome in Outpatients and Its Association with Viral Load.International journal of environmental research and public health · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. COVID-19 Cycle Threshold/Cycle Number Testing at a Community Living Center.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Blake W BuchanDepartment of Pathology, The Medical College of Wisconsin, Milwaukee.
Jessica S HoffDepartment of Microbiology and Molecular Diagnostics, Wisconsin Diagnostic Laboratories, Milwaukee.
Cameron G GmehlinSchool of Medicine, The Medical College of Wisconsin, Milwaukee.
Adriana PerezSchool of Medicine, The Medical College of Wisconsin, Milwaukee.
Matthew L FaronDepartment of Pathology, The Medical College of Wisconsin, Milwaukee.
L Silvia Munoz-PriceDepartment of Internal Medicine, Division of Infectious Disease, The Medical College of Wisconsin, Milwaukee.
Nathan A LedeboerDepartment of Pathology, The Medical College of Wisconsin, Milwaukee.
Medical College of Wisconsin · USMedical Diagnostic Laboratories (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe examined the distribution of reverse transcription polymerase chain reaction (RT-PCR) cycle threshold (CT) values obtained from symptomatic patients being evaluated for coronavirus disease 2019 (COVID-19) to determine the proportion of specimens containing a viral load near the assay limit of detection (LoD) to gain practical insight to the risk of false-negative results. We also examined the relationship between CT value and patient age to determine any age-dependent difference in viral load or test sensitivity.

methodsWe collected CT values obtained from the cobas severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) assay corresponding to 1,213 combined nasopharyngeal-oropharyngeal specimens obtained from symptomatic individuals that were reported as positive or presumptive positive for SARS-CoV-2. CT values were stratified by SARS-CoV target and patient age group.

resultsIn total, 93.3% to 98.4% of specimens demonstrated CT values greater than 3× the assay LoD, at which point false-negative results would not be expected. The mean of CT values between age groups was statistically equivalent with the exception of patients in age group 80 to 89 years, which demonstrated slightly lower CTs.

conclusionsBased on the distribution of observed CT values, including the small proportion of specimens with values near the assay LoD, there is a low risk of false-negative RT-PCR results in combined nasopharyngeal-oropharyngeal specimens obtained from symptomatic individuals.

Indexed as

Limit of DetectionReverse Transcriptase Polymerase Chain ReactionAdolescentAdultAgedAged, 80 and overAge FactorsBetacoronavirusChildChild, PreschoolClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingFalse Negative ReactionsFemaleRNA, ViralCoronavirusCOVID-19Cycle thresholdRT-PCRSARS-CoV-2Viral load

Identifiers

PMID32687186
PMCPMC7454307
OpenAlexW3042652361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.